Article
Small-Molecule Screening for Genetic Diseases
25 May 2018
Abstract excerpt
The genetic determinants of many diseases, including monogenic diseases and cancers, have been identified; nevertheless, targeted therapy remains elusive for most. High-throughput screening (HTS) of small molecules, including high-content analysis (HCA), has been an important technology for the discovery of molecular tools and new therapeutics. HTS can be based on modulation of a known disease target (called...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
